Irina Rivkind Koffler


Mizuho Top Analyst Dives In On Depomed Inc (DEPO) As The Drugmaker Exploring Sale

In pre-market trading, Depomed Inc (NASDAQ:DEPO) shares rose over 15% to $24.49 following a Reuters article indicating that the drug maker may be exploring a sale, and could begin …

Here’s Why Mizuho Top Analyst Upgraded Endo International plc – Ordinary Shares (ENDP)

Endo International plc – Ordinary Shares (NASDAQ:ENDP) just released strong second-quarter results, posting revenue of $920.9 million and EPS of $0.

Is Philidor Valeant Pharmaceuticals Intl Inc’s Achilles’ Heel?

Drug maker Valeant Pharmaceuticals Intl Inc (NYSE:VRX) faces a barrage of scrutiny, from the U.S.

Mizuho Weighs in on Valeant Pharmaceuticals Intl Inc (VRX) and Relypsa Inc (RLYP) Following Criminal Charges and 2Q:16 Report

Mizuho Securities analyst Irina Rivkind Koffler was out today with research notes on drug makers Valeant Pharmaceuticals Intl Inc (NYSE:VRX) and Relypsa Inc (NASDAQ:RLYP). The analyst …

Has the Valeant Pharmaceuticals Intl Inc (VRX) Train Left the Station? This Top Analyst Doesn’t Think So

Valeant Pharmaceuticals Intl Inc (NYSE:VRX) shares jumped over 25% yesterday, leaving investors underwhelmed. The drug maker reaffirmed its 2016 financial guidance of revenues ranging …

Mizuho Top Analyst Weighs in on Horizon Pharma PLC (HZNP) After Strong 2Q:16 Revenue Beat

Horizon Pharma PLC (NASDAQ:HZNP) just roared through its second-quarter earnings results. For the quarter, the drug maker came in with $257.

Here’s Why Mizuho Downgraded Eagle Pharmaceuticals Inc (EGRX)

In a research report issued Monday, Mizuho analyst Irina Rivkind Koffler downgraded shares of Eagle Pharmaceuticals Inc (NASDAQ:EGRX) from Buy to Neutral, while lowering the …

Mizuho Securities Weighs in on BioPharm Stocks: Valeant Pharmaceuticals Intl Inc (VRX), Horizon Pharma PLC (HZNP)

Analyst Irina Rivkind Koffler of Mizuho Securities recently commented on the overall biotech industry, highlighting several companies. Among them were Valeant Pharmaceuticals Intl …

Mizuho Reiterates Neutral on Mallinckrodt PLC Following Acquisition of Three Surgical Products

Mizuho analyst Irina Rivkind Koffler weighed in today on Mallinckrodt PLC (NYSE:MNK), after the pharmaceutical company entered into a purchase agreement with The Medicines Company to …

Mizuho Slashes Price Target for Valeant Pharmaceuticals Intl Inc (VRX) to Reflect More Conservative Approach

In a research report released Friday, Mizuho Securities analyst Irina Rivkind Koffler reiterated a Buy rating on shares of Valeant Pharmaceuticals Intl Inc (NYSE:VRX), …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts